LACC Quality of Life Results with Michael Frumovitz - a podcast by BMJ Group

In this episode of the IJGC podcast, Dr. Pedro Ramirez interviews Dr. Michael Frumovitz about his recent publication in Lancet Oncology on the quality of life endpoints from the LACC trial. Tune in! You might be very surprised with their results!

Further episodes of IJGC Podcast

Further podcasts by BMJ Group

Website of BMJ Group